Wellington Shields Capital Management Raised Edwards Lifesciences Corp. (EW) Stake; Altisource Asset Management Has 0.75 Sentiment

September 4, 2017 - By Winifred Garcia

Altisource Asset Management Corporation provides asset management and corporate governance services to institutional investors. The company has market cap of $146.27 million. The Company’s primary client is Altisource Residential Corporation . It currently has negative earnings. The Firm operates through segment, which is focused on providing asset management and certain corporate governance services to Residential.

Wellington Shields Capital Management Llc increased Edwards Lifesciences Corp. (EW) stake by 99.9% reported in 2016Q4 SEC filing. Wellington Shields Capital Management Llc acquired 15,285 shares as Edwards Lifesciences Corp. (EW)’s stock rose 25.80%. The Wellington Shields Capital Management Llc holds 30,585 shares with $2.87 million value, up from 15,300 last quarter. Edwards Lifesciences Corp. now has $23.93B valuation. The stock decreased 0.29% or $0.33 on September 1, reaching $113.31. About shares traded. Edwards Lifesciences Corp (NYSE:EW) has risen 15.41% since September 4, 2016 and is uptrending. It has underperformed by 1.29% the S&P500.

Wellington Shields Capital Management Llc decreased Salesforce.Com (NYSE:CRM) stake by 4,950 shares to 15,300 valued at $1.05M in 2016Q4. It also reduced Humana Inc (NYSE:HUM) stake by 2,600 shares and now owns 2,600 shares. Hain Celestial Group (NASDAQ:HAIN) was reduced too.

Among 26 analysts covering Edwards Lifesciences Corp (NYSE:EW), 20 have Buy rating, 1 Sell and 5 Hold. Therefore 77% are positive. Edwards Lifesciences Corp had 74 analyst reports since July 30, 2015 according to SRatingsIntel. SunTrust maintained the stock with “Neutral” rating in Monday, March 7 report. The company was maintained on Thursday, August 31 by BMO Capital Markets. The stock has “Buy” rating by Guggenheim on Tuesday, January 3. The rating was maintained by Citigroup with “Sell” on Wednesday, April 27. RBC Capital Markets maintained the shares of EW in report on Wednesday, October 26 with “Outperform” rating. William Blair reinitiated the shares of EW in report on Monday, August 28 with “Outperform” rating. The stock of Edwards Lifesciences Corp (NYSE:EW) has “Buy” rating given on Wednesday, July 27 by BTIG Research. RBC Capital Markets maintained Edwards Lifesciences Corp (NYSE:EW) on Monday, July 10 with “Buy” rating. The rating was initiated by UBS with “Buy” on Tuesday, September 22. The firm has “Buy” rating by Nomura given on Thursday, March 17.

Kazazian Asset Management Llc holds 0.58% of its portfolio in Altisource Asset Management Corp for 7,706 shares. Luxor Capital Group Lp owns 89,256 shares or 0.13% of their US portfolio. Moreover, Putnam Investments Llc has 0.04% invested in the company for 271,292 shares. The United Kingdom-based Barclays Plc has invested 0% in the stock. Blackrock Fund Advisors, a California-based fund reported 1,751 shares.

The stock increased 1.42% or $1.3 on September 1, reaching $93. About 5,300 shares traded or 62.38% up from the average. Altisource Asset Management Corp (AAMC) has risen 495.14% since September 4, 2016 and is uptrending. It has outperformed by 478.44% the S&P500.